Close Menu
Technology Mag

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Phil Spencer isn’t retiring as the chief of Xbox “anytime soon”

    July 2, 2025

    Affluent Travelers Are Ditching Business Class for Business Jets

    July 2, 2025

    The Next Acetaminophen Tablet You Take Could Be Made From PET

    July 2, 2025
    Facebook X (Twitter) Instagram
    Subscribe
    Technology Mag
    Facebook X (Twitter) Instagram YouTube
    • Home
    • News
    • Business
    • Games
    • Gear
    • Reviews
    • Science
    • Security
    • Trending
    • Press Release
    Technology Mag
    Home » 23andMe Is Sinking Fast. Can the Company Survive?
    Business

    23andMe Is Sinking Fast. Can the Company Survive?

    News RoomBy News RoomOctober 2, 20243 Mins Read
    Facebook Twitter Pinterest LinkedIn Reddit WhatsApp Email

    Kteily says by the time the company rolled out these services, it was too late. Customers had already left the platform. “I think they hit on something viral, which was the concept of where you’ve come from. People found that so fascinating. But once you know that information, you’re not going to come back five years later and pay for a subscription,” he says.

    Sumit Nagpal, a serial entrepreneur in the health tech space and a self-described early adopter of 23andMe, says he was among the company’s subscribers but eventually stopped logging into the online platform. He says the reports didn’t provide much “actionable” health advice. “It never had any life-changing value,” he says.

    Nagpal’s latest company, Cherish, which he founded in 2020, is developing radar-based sensor platforms equipped with AI for health and safety monitoring. He thinks 23andMe could have had more offerings earlier on—for instance, personalized coaching on diet, exercise, and other lifestyle factors on an ongoing basis to keep customers engaged.

    In many ways, 23andMe’s conundrum is similar to the Instant Pot problem. Its initial product was so successful that people never needed to come back to buy another one.

    23andMe has tried to diversify its revenue streams, making deals to allow pharmaceutical companies to mine its vast genetic database for drug leads. It partnered with Genentech back in 2015, and when that ended, it struck an exclusive deal with GlaxoSmithKline in 2018. The pharma company invested $300 million in 23andMe, but that agreement expired in 2023, with no big partners stepping in to fill Glaxo’s shoes. And while 23andMe recently shut down its drug discovery unit, it is continuing to advance the drug candidates it already has in clinical trials.

    Now, the company has turned to growing its telehealth business. In 2021, it acquired telehealth service Lemonaid. Capitalizing on the Ozempic craze, Lemonaid started offering Ozempic, Wegovy, and compounded semaglutide in August through a weight-loss program. After an initial consultation with a clinician, the membership is $49 per month with weight-loss medication starting at $299 a month for compounded semaglutide. “The addition of weight-loss management for our customers fits directly within our strategy of delivering services to approved individuals’ health through preventive actions,” Wojcicki said in an earnings call in August.

    But it may not be enough. Estelle Giraud, CEO and founder of Trellis Health, which is building a health app for pregnancy, says the anti-obesity space is already crowded. 23andMe will have to prove that it offers something unique compared to other telehealth providers. “If I’m a customer looking for a telehealth solution, it comes down to brand and trust,” she says.

    And establishing trust may be 23andMe’s biggest challenge after last year’s data breach exposed personal information from nearly 7 million customers’ profiles. It doesn’t help that there’s always been confusion among users over the company’s data practices. Customers must give their express consent to share their deidentified genetic data for research purposes, but one survey conducted in 2017 and 2018 by university researchers found that more than 40 percent of customers polled were not aware that using and sharing customer data was part of 23andMe’s business model. When users opted into sharing their data for research, likely many of them didn’t realize that “research” included helping Big Pharma develop new drugs.

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email
    Previous ArticlePUBG developer is making Palworld mobile amid Nintendo lawsuit
    Next Article Tesla’s cheapest Model 3 is no longer available

    Related Posts

    Affluent Travelers Are Ditching Business Class for Business Jets

    July 2, 2025

    Airplane Wi-Fi Is Now … Good?

    July 2, 2025

    Business Travel Is Evolving Faster Than Ever. We’ll Help You Navigate It

    July 2, 2025

    Airport Lounges Are Sexy Again—if You Can Get In

    July 2, 2025

    Business Class Ain’t What It Used to Be. Don’t Tell First Class

    July 2, 2025

    Sam Altman Slams Meta’s AI Talent-Poaching Spree: ‘Missionaries Will Beat Mercenaries’

    July 2, 2025
    Our Picks

    Affluent Travelers Are Ditching Business Class for Business Jets

    July 2, 2025

    The Next Acetaminophen Tablet You Take Could Be Made From PET

    July 2, 2025

    Google’s fix for Pixel 6A battery overheating issues arrives next week

    July 2, 2025

    Racist videos made with AI are going viral on TikTok

    July 2, 2025
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss
    Business

    Airplane Wi-Fi Is Now … Good?

    By News RoomJuly 2, 2025

    Expensive and erratic, in-flight Wi-Fi has been more of a punchline than a pipeline over…

    Blizzard cancels all new content for its tower defense mobile game Warcraft Rumble in light of recent heavy layoffs at parent company Microsoft.

    July 2, 2025

    How Nintendo locked down the Switch 2’s USB-C port and broke third-party docking

    July 2, 2025

    Business Travel Is Evolving Faster Than Ever. We’ll Help You Navigate It

    July 2, 2025
    Facebook X (Twitter) Instagram Pinterest
    • Privacy Policy
    • Terms of use
    • Advertise
    • Contact
    © 2025 Technology Mag. All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.